Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FMO3 gene mutations in a Korean population-Reference-Cited by-同舟云学术

Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FMO3 gene mutations in a Korean population

Published:2000-02 Issue:1 Volume:10 Page:67-78
ISSN:0960-314X
Container-title:Pharmacogenetics
language:en
Short-container-title:Pharmacogenetics

Author:

Kang Ju-Hee,Chung Woon-Gye,Lee Kyung-Hoon,Park Chang-Shin,Kang Ju-Seop,Shin In-Chul,Roh Hyung-Keun,Dong Mi-Sook,Baek Hyun-Moon,Cha Young-Nam

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Pharmacology, Toxicology and Pharmaceutics,Genetics

Reference26 articles.

1. The fish odour syndrome: biochemical, familial, and clinical aspects.

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions;Archives of Toxicology;2022-06-01

2. Population Pharmacokinetics of Sulindac and Genetic Polymorphisms of FMO3 and AOX1 in Women with Preterm Labor;Pharmaceutical Research;2020-01-28

3. Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota;International Journal of Biological Sciences;2020

4. Flavin-containing monooxygenase 3 (FMO3): genetic variants and their consequences for drug metabolism and disease;Xenobiotica;2019-08-01

5. Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug‐Drug Interactions With Ethionamide Involving Impact of Genetic Polymorphism on FMO3;The Journal of Clinical Pharmacology;2019-01-28